With the advancement in technology and in people’s lifestyle, the cases of genetic disorder or abnormalities have increased significantly. Simultaneously, there has been advancement in the healthcare technology to tackle the modern age problems. Prenatal testing and newborn screening is the most modernized trends in the healthcare industry with a tremendous level of progress in the last few years. The high fetal mortality rate and advancement in healthcare technology are the factors responsible for the growth of prenatal and newborn screening market. The global prenatal and newborn screening market is expected to reach $10.63 billion by the end of 2022. The gradual rise in the new prenatal diagnosis and newborn screening tests is attributed to the emergence of advanced technologies such as next generation sequencing, high throughput screening, and cell free fetal DNA.